Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Return on Sales (2020 - 2025)

Rapid Micro Biosystems' Return on Sales history spans 6 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Sales hit 0.01% in Q4 2025 for Rapid Micro Biosystems, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Sales for RPID hit a ceiling of 0.01% in Q4 2025 and a floor of 0.04% in Q1 2021.
  • Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.02% in 2023.
  • The widest YoY moves for Return on Sales: up 2bps in 2021, down -8bps in 2021.
  • Tracing RPID's Return on Sales over 5 years: stood at 0.03% in 2021, then tumbled by -34bps to 0.04% in 2022, then skyrocketed by 53bps to 0.02% in 2023, then soared by 33bps to 0.01% in 2024, then increased by 6bps to 0.01% in 2025.
  • Business Quant data shows Return on Sales for RPID at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.02% in Q2 2025.